SCHEMBL2298649

SCHEMBL2298649

CC(C(=O)O)[C@H](c1ccccc1)n1cnc2cc(NC(=O)Nc3ccccc3)ccc21

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 11/20 0.47
NPC1 O15118 10/20 0.47
EGFR P00533 1/20 0.44
NR1I2 O75469 2/20 0.44
SMN1; SMN2 Q16637 6/20 0.43
LMNA P02545 2/20 0.43
KDM4E B2RXH2 3/20 0.42
GFER P55789 1/20 0.42
ALDH1A1 P00352 3/20 0.42
MAPT P10636 2/20 0.42
HCAR3 P49019 1/20 0.42
RECQL P46063 1/20 0.41
KMT2A Q03164 2/20 0.41
HSD17B10 Q99714 1/20 0.40
MEN1 O00255 1/20 0.40
TP53 P04637 1/20 0.40
HTT P42858 1/20 0.40
GAA P10253 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2295171 0.81 HCAR3 (0.46) RAB9ANPC1NR1I2SMN1; SMN2KDM4E
SCHEMBL2296252 0.79 NR1I2 (0.47) RAB9ANPC1EGFRNR1I2SMN1; SMN2
SCHEMBL2296670 0.79 NR1I2 (0.47) RAB9ANPC1EGFRNR1I2SMN1; SMN2
SCHEMBL2298641 0.78 NR1I2 (0.44) RAB9ANPC1EGFRNR1I2SMN1; SMN2
SCHEMBL12421967 0.77 NR1I2 (0.45) RAB9ANPC1EGFRNR1I2SMN1; SMN2
SCHEMBL12420930 0.77 NR1I2 (0.45) RAB9ANPC1EGFRNR1I2SMN1; SMN2
SCHEMBL2292931 0.77 ALDH1A1 (0.52) SMN1; SMN2KDM4EALDH1A1MAPTHCAR3
SCHEMBL2296414 0.76 MAPT (0.44) RAB9ANPC1NR1I2SMN1; SMN2LMNA
SCHEMBL5299923 0.74 NR1I2 (0.44) RAB9ANPC1NR1I2SMN1; SMN2LMNA
SCHEMBL5301184 0.74 RAB9A (0.44) RAB9ANPC1NR1I2SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003806-B2 Integrin antagonists useful as anticancer agents OSI Pharmaceuticals, LLC (US) 2011-08-23 US disclosed